Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-01 8:30 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC. MRNS | Panacea Innovation Ltd | 5,500,000 9.980% | 5,500,000 (New Position) | View |
| 2024-07-01 4:16 pm Purchase | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Ltd | 13,410,000 24.300% | 1,410,000 (+11.75%) | View |
| 2024-03-11 08:44 am Purchase | 13G | Amylyx Pharmaceuticals Inc. AMLX | Panacea Innovation Ltd | 4,200,000 6.200% | 4,200,000 (New Position) | View |
| 2024-02-27 9:00 pm Purchase | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Ltd | 12,000,000 21.800% | 3,100,000 (+34.83%) | View |
| 2024-02-13 4:30 pm Purchase | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Ltd | 8,900,000 16.200% | 8,900,000 (New Position) | View |